Review demonstrates safe and effective defect closure using hybrid perventricular devices in congenital ventricular septal defect patients, highlighting a viable alternative to open surgery.
Ventricular septal defect (VSD) is a common congenital heart disease. Open surgical repair with cardiopulmonary bypass (CPB) and sternotomy is the classic treatment. Percutaneous device closure is a minimally invasive alternative in treating selected VSDs, but it is limited by vascular access as well as radiation exposure especially in pediatric patients. Hybrid perventricular device closure of VSDs was designed to combine the advantages of both approaches allowing direct access to the defect without CPB and has gained wider acceptance in recent years. Under transesophageal echocardiography guidance, it could effectively close muscular, perimembranous, and even doubly committed defects. It is a safe and effective option for selected patients with congenital VSDs. In this article, we reviewed the application and results of this technique.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: